Balance Wealth’s AbbVie ABBV Stock Holding History

Balance Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$150K	Buy	+574	New	+$147K	0.04%	191

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Balance Wealth's ABBV Position: Q3 2026 in Review

Balance Wealth opened a new position in AbbVie (ABBV) in Q3 2026: 574 shares worth $150K. The stake represents 0.04% of the portfolio and ranks #191 among its holdings.

2,888 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Balance Wealth held 574 shares of AbbVie worth $150K as of Q3 2026.
AbbVie was a new Balance Wealth position in Q3 2026.
AbbVie made up 0.04% of Balance Wealth's portfolio in Q3 2026, its #191 holding.
2,888 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.